LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients-Reference-Cited by-同舟云学术

LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients

Published:2018-12-30 Issue:3 Volume:34 Page:406-415
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Atashrazm Farzaneh¹,Hammond Deborah²,Perera Gayathri¹,Bolliger Marc F.³,Matar Elie¹²,Halliday Glenda M.¹⁴⁵^ORCID,Schüle Birgitt³,Lewis Simon J.G.¹²,Nichols R. Jeremy³,Dzamko Nicolas¹⁴⁵^ORCID

Affiliation:

1. Brain and Mind CentreCentral Clinical School, University of Sydney Camperdown NSW Australia

2. Forefront Parkinson's Disease Research Clinic, Brain and Mind CentreUniversity of Sydney Camperdown NSW Australia

3. Parkinson's Institute and Clinical Center Sunnyvale California USA

4. Neuroscience Research Australia Randwick NSW Australia

5. School of Medical SciencesUniversity of NSW Kensington NSW Australia

Funder

Michael J. Fox Foundation for Parkinson's Research

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27601

Reference39 articles.

1. LRRK2gene variation and its contribution to Parkinson disease

2. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

3. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

4. Large-scale replication and heterogeneity in Parkinson disease genetic loci

5. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rab10-CAV1 mediated intraluminal vesicle transport to migrasomes;Proceedings of the National Academy of Sciences;2024-07-15

2. The Evolution of Genetic Variability at the LRRK2 Locus;Genes;2024-07-03

3. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage;npj Parkinson's Disease;2024-03-01

4. Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases;Cell & Bioscience;2024-02-12

5. Post-translational modification and mitochondrial function in Parkinson’s disease;Frontiers in Molecular Neuroscience;2024-01-11